News Release Details
Entegris Reports Results for First Quarter Of 2022
- First-quarter revenue of
$650 million , increased 27% from prior year - First-quarter GAAP diluted EPS of
$0.92 , increased 48% - First-quarter non-GAAP diluted EPS of
$1.06 , increased 51%
First-quarter sales were
Quarterly Financial Results Summary |
|||
(in thousands, except percentages and per share data) |
|||
GAAP Results |
|
|
|
Net sales |
|
|
|
Operating income |
|
|
|
Operating margin - as a % of net sales |
25.1% |
22.2% |
25.1% |
Net income |
|
|
|
Diluted earnings per common share |
|
|
|
Non-GAAP Results |
|||
Non-GAAP adjusted operating income |
|
|
|
Non-GAAP adjusted operating margin - as a % of net sales |
28.1% |
25.0% |
27.8% |
Non-GAAP net income |
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
Second-Quarter Outlook
For the second quarter ending July
Segment Results
The Company reports its results in the following segments:
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases and materials, and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC offers solutions to filter and purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport and deliver critical liquid chemistries, wafers and other substrates for a broad set of applications in the semiconductor, life sciences and other high-technology industries.
First-Quarter Results Conference Call Details
Entegris will hold a conference call to discuss its results for the first quarter on
Management’s slide presentation concerning the results for the first quarter will be posted on the Investor Relations section of www.entegris.com Tuesday morning before the call.
About Entegris
Entegris is a world-class supplier of advanced materials and process solutions for the semiconductor and other high-tech industries. Entegris has approximately 6,600 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service and/or research facilities in
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Additional Information about the Acquisition and Where to Find It
This news release does not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities or a solicitation of any vote or approval. This news release relates to a proposed business combination between
Cautionary Note on Forward Looking Statements
This news release may contain statements that are not historical facts and are “forward-looking statements” within the meaning of
|
||||
Condensed Consolidated Statements of Operations |
||||
(In thousands, except per share data) |
||||
(Unaudited) |
||||
|
|
Three months ended |
||
|
|
|
|
|
Net sales |
|
|
|
|
Cost of sales |
339,826 |
277,858 |
340,114 |
|
|
Gross profit |
309,820 |
234,986 |
295,090 |
Selling, general and administrative expenses |
87,108 |
71,389 |
77,366 |
|
Engineering, research and development expenses |
46,715 |
37,748 |
45,940 |
|
Amortization of intangible assets |
12,651 |
11,871 |
12,240 |
|
|
Operating income |
163,346 |
113,978 |
159,544 |
Interest expense, net |
12,864 |
11,581 |
9,434 |
|
Other expense, net |
4,902 |
4,330 |
1,888 |
|
|
Income before income tax expense |
145,580 |
98,067 |
148,222 |
Income tax expense |
19,875 |
13,391 |
30,003 |
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
||
Basic earnings per common share: |
|
|
|
|
Diluted earnings per common share: |
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
Basic |
135,670 |
135,068 |
135,495 |
|
Diluted |
136,552 |
136,502 |
136,629 |
|
|||||
Condensed Consolidated Balance Sheets |
|||||
(In thousands) |
|||||
(Unaudited) |
|||||
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
|
|
|||
Trade accounts and notes receivable, net |
372,759 |
347,413 |
|||
Inventories, net |
|
545,607 |
475,213 |
||
Deferred tax charges and refundable income taxes |
34,755 |
35,312 |
|||
Other current assets |
63,482 |
52,867 |
|||
Total current assets |
1,369,335 |
1,313,370 |
|||
Property, plant and equipment, net |
698,574 |
654,098 |
|||
Other assets: |
|
|
|
|
|
Right-of-use assets |
69,713 |
66,563 |
|||
|
793,861 |
793,702 |
|||
Intangible assets, net |
322,289 |
335,113 |
|||
Deferred tax assets and other noncurrent tax assets |
17,820 |
17,671 |
|||
Other |
|
11,848 |
11,379 |
||
Total assets |
|
|
|
||
LIABILITIES AND EQUITY |
|
||||
Current liabilities |
|
|
|
||
Accounts payable |
|
|
|
||
Accrued liabilities |
|
173,031 |
199,131 |
||
Income tax payable |
|
64,674 |
49,136 |
||
Total current liabilities |
371,661 |
379,001 |
|||
Long-term debt, excluding current maturities |
937,349 |
937,027 |
|||
Long-term lease liability |
|
62,110 |
60,101 |
||
Other liabilities |
|
92,002 |
101,986 |
||
Shareholders’ equity |
|
1,820,318 |
1,713,781 |
||
Total liabilities and equity |
|
|
|||
|
||
Condensed Consolidated Statements of Cash Flows |
||
(In thousands) |
||
(Unaudited) |
||
|
Three months ended |
|
|
|
|
Operating activities: |
|
|
Net income |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
Depreciation |
23,905 |
22,095 |
Amortization |
12,651 |
11,871 |
Stock-based compensation expense |
9,285 |
7,138 |
Other |
195 |
8,166 |
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
Trade accounts and notes receivable |
(31,171) |
(21,564) |
Inventories |
(77,476) |
(39,337) |
Accounts payable and accrued liabilities |
(22,323) |
(28,591) |
Income taxes payable, refundable income taxes and noncurrent taxes payable |
16,760 |
(3,588) |
Other |
6,257 |
12,249 |
Net cash provided by operating activities |
63,788 |
53,115 |
Investing activities: |
|
|
Acquisition of property and equipment |
(84,405) |
(43,330) |
Other |
1,123 |
72 |
Net cash used in investing activities |
(83,282) |
(43,258) |
Financing activities: |
|
|
Proceeds from revolving credit facility and long-term debt |
79,000 |
— |
Payments of revolving credit facility and long-term debt |
(79,000) |
— |
Payments for dividends |
(13,895) |
(10,908) |
Issuance of common stock |
3,379 |
1,572 |
Taxes paid related to net share settlement of equity awards |
(16,117) |
(15,038) |
Repurchase and retirement of common stock |
— |
(15,000) |
Other |
(962) |
(1) |
Net cash (used in) financing activities |
(27,595) |
(39,375) |
Effect of exchange rate changes on cash and cash equivalents |
(2,744) |
(2,855) |
(Decrease) in cash and cash equivalents |
(49,833) |
(32,373) |
Cash and cash equivalents at beginning of period |
402,565 |
580,893 |
Cash and cash equivalents at end of period |
|
|
|
|||
Segment Information |
|||
(In thousands) |
|||
(Unaudited) |
|||
|
Three months ended |
||
Net sales |
|
|
|
Specialty Chemicals and Engineered Materials |
|
|
|
Microcontamination Control |
266,637 |
207,099 |
258,866 |
Advanced Materials Handling |
198,113 |
148,541 |
197,703 |
Inter-segment elimination |
(11,525) |
(9,337) |
(9,369) |
Total net sales |
|
|
|
|
Three months ended |
||
Segment profit |
|
|
|
Specialty Chemicals and Engineered Materials |
|
|
|
Microcontamination Control |
98,618 |
70,566 |
94,203 |
Advanced Materials Handling |
46,690 |
32,095 |
45,304 |
Total segment profit |
194,159 |
137,217 |
186,722 |
Amortization of intangibles |
12,651 |
11,871 |
12,240 |
Unallocated expenses |
18,162 |
11,368 |
14,938 |
Total operating income |
|
|
|
|
|||
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit |
|||
(In thousands) |
|||
(Unaudited) |
|||
|
Three months ended |
||
|
|
|
|
Net sales |
|
|
|
Gross profit-GAAP |
|
|
|
Adjustments to gross profit: |
|
|
|
Charge for fair value mark-up of acquired inventory sold |
— |
— |
428 |
Adjusted gross profit |
|
|
|
|
|
|
|
Gross margin - as a % of net sales |
47.7% |
45.8% |
46.5% |
Adjusted gross margin - as a % of net sales |
47.7% |
45.8% |
46.5% |
|
|||
Reconciliation of GAAP Segment Profit to Adjusted Operating Income |
|||
(In thousands) |
|||
(Unaudited) |
|||
|
Three months ended |
||
Segment profit-GAAP |
|
|
|
Specialty Chemicals and Engineered Materials (SCEM) |
|
|
|
Microcontamination Control (MC) |
98,618 |
70,566 |
94,203 |
Advanced Materials Handling (AMH) |
46,690 |
32,095 |
45,304 |
Total segment profit |
194,159 |
137,217 |
186,722 |
Amortization of intangible assets |
12,651 |
11,871 |
12,240 |
Unallocated expenses |
18,162 |
11,368 |
14,938 |
Total operating income |
|
|
|
|
Three months ended |
||
Adjusted segment profit |
|
|
|
SCEM segment profit |
|
|
|
Severance and restructuring costs |
— |
47 |
— |
Charge for fair value write-up of acquired inventory sold |
— |
— |
428 |
SCEM adjusted segment profit |
|
|
|
|
|
|
|
MC segment profit |
|
|
|
Severance and restructuring costs |
— |
51 |
— |
MC adjusted segment profit |
|
|
|
|
|
|
|
AMH segment profit |
|
|
|
Severance and restructuring costs |
— |
37 |
— |
AMH adjusted segment profit |
|
|
|
|
|
|
|
Unallocated general and administrative expenses |
|
|
|
Unallocated deal and integration costs |
(6,254) |
(2,044) |
(4,558) |
Unallocated severance and restructuring costs |
— |
(8) |
— |
Adjusted unallocated general and administrative expenses |
|
|
|
|
|
|
|
Total adjusted segment profit |
|
|
|
Adjusted amortization of intangible assets |
— |
— |
— |
Adjusted unallocated general and administrative expenses |
11,908 |
9,316 |
10,380 |
Total adjusted operating income |
|
|
|
|
|||
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA |
|||
(In thousands) |
|||
(Unaudited) |
|||
|
Three months ended |
||
|
|
|
|
Net sales |
|
|
|
Net income |
|
|
|
Net income - as a % of net sales |
19.3% |
16.5% |
18.6% |
Adjustments to net income: |
|
|
|
Income tax expense |
19,875 |
13,391 |
30,003 |
Interest expense, net |
12,864 |
11,581 |
9,434 |
Other expense, net |
4,902 |
4,330 |
1,888 |
GAAP - Operating income |
163,346 |
113,978 |
159,544 |
Operating margin - as a % of net sales |
25.1% |
22.2% |
25.1% |
Charge for fair value write-up of acquired inventory sold |
— |
— |
428 |
Deal and transaction costs |
5,008 |
— |
4,744 |
Integration costs |
1,246 |
2,044 |
(186) |
Severance and restructuring costs |
— |
143 |
— |
Amortization of intangible assets |
12,651 |
11,871 |
12,240 |
Adjusted operating income |
182,251 |
128,036 |
176,770 |
Adjusted operating margin - as a % of net sales |
28.1% |
25.0% |
27.8% |
Depreciation |
23,905 |
22,095 |
22,801 |
Adjusted EBITDA |
|
|
|
Adjusted EBITDA - as a % of net sales |
31.7% |
29.3% |
31.4% |
|
|||
Reconciliation of GAAP Net Income and Diluted Earnings per Common Share to Non-GAAP Net Income and Diluted |
|||
(In thousands, except per share data) |
|||
(Unaudited) |
|||
|
Three months ended |
||
|
|
|
|
GAAP net income |
|
|
|
Adjustments to net income: |
|
|
|
Charge for fair value write-up of inventory acquired |
— |
— |
428 |
Deal and transaction costs |
5,008 |
— |
4,744 |
Integration costs |
1,246 |
2,044 |
(186) |
Severance and restructuring costs |
— |
143 |
— |
Term loan ticking fee |
4,683 |
— |
— |
Amortization of intangible assets |
12,651 |
11,871 |
12,240 |
Tax effect of adjustments to net income and discrete items1 |
(4,160) |
(3,221) |
(3,662) |
Non-GAAP net income |
|
|
|
|
|
|
|
Diluted earnings per common share |
|
|
|
Effect of adjustments to net income |
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
1 |
The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years. |
|
|
Reconciliation of GAAP Outlook to Non-GAAP Outlook |
|
(In millions, except per share data) |
|
(Unaudited) |
|
|
Second-Quarter Outlook |
Reconciliation GAAP net income to non-GAAP net income |
|
GAAP net income |
|
Adjustments to net income: |
|
Deal, transaction and integration costs |
17 |
Amortization of intangible assets |
12 |
Interest costs relating to financing of CMC transaction |
31 |
Income tax effect |
(12) |
Non-GAAP net income |
|
|
Second-Quarter Outlook |
Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share |
|
Diluted earnings per common share |
|
Adjustments to diluted earnings per common share: |
|
Deal, transaction and integration costs |
0.12 |
Amortization of intangible assets |
0.09 |
Interest costs relating to financing of CMC transaction |
0.23 |
Income tax effect |
(0.09) |
Diluted non-GAAP earnings per common share |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005465/en/
VP of Investor Relations and
T + 1 952 556 1844
bill.seymour@entegris.com
Source: